These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 33605149)

  • 61. Prediction of retinopathy at 20 years after onset in younger-onset type 1 diabetes using mean metabolic memory-free HbA1c values: the importance of using HbA1c data of total, not partial, diabetes duration.
    Hirose A; Furushima D; Yamaguchi N; Kitano S; Uchigata Y
    Diabetes Care; 2013 Nov; 36(11):3812-4. PubMed ID: 24026558
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).
    Ólafsdóttir AF; Bolinder J; Heise T; Polonsky W; Ekelund M; Wijkman M; Pivodic A; Ahlén E; Schwarcz E; Nyström T; Hellman J; Hirsch IB; Lind M
    Diabetes Obes Metab; 2021 Feb; 23(2):619-630. PubMed ID: 33200487
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Panretinal Photocoagulation Versus Ranibizumab for Proliferative Diabetic Retinopathy: Factors Associated with Vision and Edema Outcomes.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Melia M; Chen E; Pavlica MR; Jampol LM;
    Ophthalmology; 2018 Nov; 125(11):1776-1783. PubMed ID: 29980333
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HbA1c levels in children with type 1 diabetes and correlation to diabetic retinopathy.
    Andreasson R; Ekelund C; Landin-Olsson M; Nilsson C
    J Pediatr Endocrinol Metab; 2018 Mar; 31(4):369-374. PubMed ID: 29494341
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Efficacy and safety of generic exenatide injection in Chinese patients with type 2 diabetes: a multicenter, randomized, controlled, non-inferiority trial.
    Yang J; Xiao W; Guo L; Li Q; Zhong L; Yang J; Yang J; Gao Y; Tian Q; Hong T
    Acta Diabetol; 2020 Aug; 57(8):991-1000. PubMed ID: 32206903
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Improvement in Neuropathy Outcomes With Normalizing HbA
    Ishibashi F; Taniguchi M; Kosaka A; Uetake H; Tavakoli M
    Diabetes Care; 2019 Jan; 42(1):110-118. PubMed ID: 30455338
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Retinal characteristics during 1 year of insulin pump therapy in type 1 diabetes: a prospective, controlled, observational study.
    Klefter ON; Hommel E; Munch IC; Nørgaard K; Madsbad S; Larsen M
    Acta Ophthalmol; 2016 Sep; 94(6):540-7. PubMed ID: 27126300
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prolonged effect of intensive therapy on the risk of retinopathy complications in patients with type 1 diabetes mellitus: 10 years after the Diabetes Control and Complications Trial.
    White NH; Sun W; Cleary PA; Danis RP; Davis MD; Hainsworth DP; Hubbard LD; Lachin JM; Nathan DM
    Arch Ophthalmol; 2008 Dec; 126(12):1707-15. PubMed ID: 19064853
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.
    Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E
    J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited.
    Engelgau MM; Thompson TJ; Herman WH; Boyle JP; Aubert RE; Kenny SJ; Badran A; Sous ES; Ali MA
    Diabetes Care; 1997 May; 20(5):785-91. PubMed ID: 9135943
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.
    Lancet; 1998 Sep; 352(9131):837-53. PubMed ID: 9742976
    [TBL] [Abstract][Full Text] [Related]  

  • 73. HbA1c variability is associated with an increased risk of retinopathy requiring laser treatment in type 1 diabetes.
    Hietala K; Wadén J; Forsblom C; Harjutsalo V; Kytö J; Summanen P; Groop PH;
    Diabetologia; 2013 Apr; 56(4):737-45. PubMed ID: 23314044
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Long-term visit-to-visit glycemic variability as predictor of micro- and macrovascular complications in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Moram CBM; Salles GF
    Cardiovasc Diabetol; 2018 Feb; 17(1):33. PubMed ID: 29477146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.
    Deshmukh H; Wilmot EG; Gregory R; Barnes D; Narendran P; Saunders S; Furlong N; Kamaruddin S; Banatwalla R; Herring R; Kilvert A; Patmore J; Walton C; Ryder REJ; Sathyapalan T
    Diabetes Care; 2020 Sep; 43(9):2153-2160. PubMed ID: 32669277
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial.
    Steffes MW; Sibley S; Jackson M; Thomas W
    Diabetes Care; 2003 Mar; 26(3):832-6. PubMed ID: 12610045
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The importance of low HbA1c during childhood on glycaemic control in adulthood and the risk of late complications.
    Samuelsson U; Anderzen J; Åkesson K; Hanberger L
    Acta Paediatr; 2021 Apr; 110(4):1264-1272. PubMed ID: 32978990
    [TBL] [Abstract][Full Text] [Related]  

  • 78. HbA1c variability as an independent risk factor for diabetic retinopathy in type 1 diabetes: a German/Austrian multicenter analysis on 35,891 patients.
    Hermann JM; Hammes HP; Rami-Merhar B; Rosenbauer J; Schütt M; Siegel E; Holl RW;
    PLoS One; 2014; 9(3):e91137. PubMed ID: 24609115
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Are there any glycemic thresholds for the serious microvascular diabetic complications?
    Reichard P
    J Diabetes Complications; 1995; 9(1):25-30. PubMed ID: 7734740
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glycemic control and complications in patients with type 1 diabetes - a registry-based longitudinal study of adolescents and young adults.
    Carlsen S; Skrivarhaug T; Thue G; Cooper JG; Gøransson L; Løvaas K; Sandberg S
    Pediatr Diabetes; 2017 May; 18(3):188-195. PubMed ID: 26875589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.